Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent
2 other identifiers
interventional
80
1 country
1
Brief Summary
The purpose of this study is to compare the quality of life in patients with unresectable hilar cholangiocarcinoma on palliative metallic stent versus plastic Stent.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Jan 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 3, 2008
CompletedFirst Posted
Study publicly available on registry
September 4, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2009
CompletedSeptember 4, 2008
July 1, 2008
1.2 years
September 3, 2008
September 3, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To assessment of the quality of life of patient with unresectable hilar cholangiocarcinoma after palliative biliary stent.
2-4 weeks
Secondary Outcomes (2)
To assessment of early and late complication after palliative stent.
After stent insertion for sixth month and one year or until patients were expired
Survival rate at sixth month and one year.
After stent insertion for sixth month and one year or until patients were expired
Study Arms (2)
1
EXPERIMENTALmetallic stent group
2
ACTIVE COMPARATORplastic stent group
Interventions
Metallic stent of plastic stent was inserted into right or left hepatic duct which was planed before intervention using CT scan or MRCP
Eligibility Criteria
You may qualify if:
- All patient with diagnosis of hilar cholangiocarcinoma and/or radiological diagnosis
- Patient considered having an unresectable tumor or unfit of operation because of advanced age or medical illness
You may not qualify if:
- Patient with ASA 4 or 5
- Patient who inability to comply with follow up
- Patient refused to join the research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Srinagarind Hospital.KhonKaen University.
Muang, KhonKaen, Thailand
Related Publications (1)
De Palma GD, Pezzullo A, Rega M, Persico M, Patrone F, Mastantuono L, Persico G. Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest Endosc. 2003 Jul;58(1):50-3. doi: 10.1067/mge.2003.310.
PMID: 12838220RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Worrarat Kongkasame, MD
Department of Medicine.Faculty of Medicine .KhonKaen University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 3, 2008
First Posted
September 4, 2008
Study Start
January 1, 2008
Primary Completion
March 1, 2009
Study Completion
July 1, 2009
Last Updated
September 4, 2008
Record last verified: 2008-07